Global Cartilage Repair Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Cartilage Repair Market was valued at $2.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 9.5% CAGR, to an estimated market size of $3.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global cartilage repair market comprises medical procedures, biomaterials, and cell-based therapies designed to restore or regenerate damaged articular cartilage in synovial joints, primarily the knee, hip, and ankle. The scope includes marrow stimulation, autologous chondrocyte implantation (ACI), osteochondral grafts, and scaffolds, while excluding total joint replacement hardware and routine physical therapy.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Cartilage Repair Market in the period 2025-30:
- There is a significant strategic shift in orthopedics from total joint replacement toward joint preservation techniques to maintain natural biomechanics.
- The rising global prevalence of osteoarthritis, projected to affect nearly one billion people by 2050, is the primary long-term market driver.
- Advancements in 3D bioprinting and tissue engineering are enabling the creation of patient-specific scaffolds for complex cartilage defects.
- Increased adoption of minimally invasive arthroscopic delivery methods is reducing recovery times and improving patient acceptance of surgical repair.
- Regulatory milestones, such as FDA approvals for matrix-induced autologous chondrocyte implantation (MACI), are expanding the commercial availability of advanced biologics.
- The growing incidence of sports-related injuries among younger populations is driving demand for early-stage restorative interventions.
- High procedural costs and complex reimbursement pathways remain significant barriers to adoption in price-sensitive and developing markets.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Cell-based Therapies
- Non-cell-based & Scaffolds